Health
AACR: MD Anderson team uncovers new target for blocking mutant KRAS and p53 in pancreatic cancer – FierceBiotech
An MD Anderson team discovered that mutant KRAS and p53 rely on a protein called CREB1 to drive the growth and spread of pancreatic cancer. Blocking CREB1 in mouse…
Mutations in the genes KRAS and p53 have been tied to several tumor types, including pancreatic cancer. Scientists at the University of Texas MD Anderson Cancer Center say they have found a critical link between the two abnormal genes and tumor growth in pancreatic cancerand theyre proposing a way to block it.
The MD Anderson team discovered that mutant KRAS and p53 rely on a protein called CREB1 to drive the growth and spread of pancreatic cancer. Blocking CREB1 in mouse models of the disease reduced…
-
General17 hours agoAlleged Croydon Park gunman Artemios Mintzas charged with 25 offences
-
Noosa News23 hours agoYork family honours late son with tractor museum to fund cancer research
-
General23 hours agoTeam Australia wins back-to-back Motocross of Nations titles
-
Noosa News19 hours agoPerth Royal Show attendance slumps to 10-year low